Hong Kong Pharma Digital (HKPD) Stock Analysis: AI Score & Alternative Data
Hong Kong Pharma Digital — alt-data steady across 90 days
Is Hong Kong Pharma Digital a buy right now? The alternative data says hold. This HKPD stock analysis is built on the 25+ alternative data signals AltIndex tracks on Hong Kong Pharma Digital every day — hiring, web traffic, sentiment, social reach — rolled into an AI Score of 52/100: a Hold. The stock trades at $0.41 with a $10M market cap.
No core signal has moved more than 5% in 90 days — steady, but without the momentum that pushes a stock into buy territory.
HKPD’s broader alt-data profile also covers quarterly revenue ($10M), and sentiment (83/100). Every signal links to its own page with full history, the HKPD technical analysis covers RSI, moving averages, and support and resistance, and the full table of everything AltIndex tracks on HKPD is just below.
Hong Kong Pharma Digital AI Stock Analysis
Hong Kong Pharma Digital is an emerging player in the digital pharmaceutical industry. The company focuses on leveraging digital technologies to enhance pharmaceutical manufacturing, distribution, and healthcare services.
Analysis generated July 31, 2026.
Recent Hong Kong Pharma Digital Stock Alerts
|
Hong Kong Pharma Digital | August 13 Price is down by -7.2% in the last 24h. |
|
Hong Kong Pharma Digital | August 11 Price is down by -9.4% in the last 24h. |
|
Hong Kong Pharma Digital | August 5 Price is down by -7.1% in the last 24h. |
|
Hong Kong Pharma Digital | August 3 Price is down by -7.3% in the last 24h. |
Hong Kong Pharma Digital Alternative Data
| Alternative Data | Value | 3m Change | Trend |
|---|---|---|---|
| Webpage Traffic | 0 | N/A | |
| Sentiment | 83 | N/A | |
| Reddit Mentions | 0 | N/A | |
| X Mentions | 1 | N/A | |
| Stocktwits Mentions | 0 | 100.0% | |
| News Mentions | 0 | N/A | |
| Stocktwits Subscribers | 589 | 0% |
About Hong Kong Pharma Digital (HKPD)
Hong Kong Pharma Digital Technology Holdings Limited is a pioneering company at the intersection of biotechnology and digital healthcare, focusing on the integration of cutting-edge technology with pharmaceutical services to enhance patient outcomes and streamline healthcare delivery. Leveraging advanced digital solutions and data analytics, the company optimizes drug development processes and improves operational efficiencies, positioning itself as a critical player in the evolving healthcare landscape. With a strong commitment to health technology advancement and the cultivation of strategic alliances, Hong Kong Pharma is poised to meet the demands of both domestic and global markets while driving innovation across its pharmaceutical service offerings.
| Price | $0.41 |
| Target Price | $387.74 |
| Volume | 63,420,177 |
| Market Cap | $10M |
| Year Range | $0 – $2 |
| Dividend Yield | 0% |
| PE Ratio | — |
| Analyst Rating | 38% buy |
| Industry | Health Care Services |
Latest Hong Kong Pharma Digital News
View more →
Cellyan Biotechnology Co., Ltd Receives Nasdaq Notice of Additional Compliance Grace PeriodJuly 16 - GlobeNewswire |
Hong Kong Pharma Digital Earnings & Financial Performance
View all earnings →Hong Kong Pharma Digital Insider Trading Activity
View all →| No recent insider transactions on file. |
Hong Kong Pharma Digital Congress Trading
View all →| Politician | Filing Date | Type | Size |
|---|---|---|---|
| No congress trades on file. | |||
Stocks Similar to Hong Kong Pharma Digital
See all →| Company | Price | Market Cap | AI Score | |
|---|---|---|---|---|
 |
XWELLXWEL |
$0.94 4.5% | $8M | 44 |
 |
Check-CapMBAI |
$8.02 8.1% | $12M | 48 |
 |
Cosmos HealthCOSM |
$0.21 5.0% | $14M | 48 |
 |
ENDRA Life SciencesNDRA |
$4.48 0.1% | $6M | 46 |
 |
Advanced BiomedADVB |
$8.30 7.3% | $15M | 49 |
Explore Hong Kong Pharma Digital Data
Frequently Asked Questions: Hong Kong Pharma Digital (HKPD)
Hong Kong Pharma Digital has an AltIndex AI Score of 52/100 (Hold). The score reflects mixed alternative data signals. All investments carry risk.
52/100. The AI Score combines 25+ alternative data signals including job postings, employee sentiment, social media, web traffic, and financials. Scores above 60 = buy, 40–59 = hold, below 40 = sell. Updated daily.
Currently, the price of one share of Hong Kong Pharma Digital (HKPD) stock is $0.41 with a market cap of $10M.
As of today, Hong Kong Pharma Digital’s PE (Price to Earnings) ratio is —.
View the latest Hong Kong Pharma Digital insider transactions to see recent buying and selling activity by company executives and directors.
Check the Hong Kong Pharma Digital congress trading page for the latest disclosed trades by U.S. senators and representatives.
AltIndex tracks 25+ signals including job postings, web traffic, employee sentiment, Reddit mentions, Stocktwits activity, insider transactions, congressional trades, Google Trends, app downloads, and more.
The HKPD stock price chart above shows Hong Kong Pharma Digital’s performance over time alongside its AI Score. Investors can identify patterns, trends, and potential support or resistance levels. View the full Hong Kong Pharma Digital technical analysis for RSI, moving averages, and more.
See the stocks similar to Hong Kong Pharma Digital section on this page for companies in the same industry ranked by market cap and AI Score.
